Evidence map›Paper›PMID 40867038›Full record

ArticleJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology2025

Metabolic Heterogeneity Confers Differences in the Tumor Microenvironment of Aggressive Types of Melanomas.

Juliana de Souza do Nascimento, João Figueira Scarini, Erika Said Abu Egal, Marcelo Brum Corrêa, Rodrigo Ribas Dias Dos Reis, Luciana Schultz Amorim, Rachel Martins Marinho Robim, Clóvis Antônio Lopes Pinto, Patricia Maria Peresi, Ana Lucia Noronha Francisco and 5 more

Abstract read
In one paragraph

Article in Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Metabolic Heterogeneity Confers Differences in the Tumor Microenvironment of Aggressive Types of Melanomas.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Juliana de Souza do NascimentoDepartment of Pathology, Faculty of Medical Sciences, University of Campinas (UNICAMP), São Paulo, Brazil.
João Figueira ScariniDepartment of Pathology, Faculty of Medical Sciences, University of Campinas (UNICAMP), São Paulo, Brazil.ORCID https://orcid.org/0000-0001-9015-6831
Erika Said Abu EgalDepartment of Pathology, Faculty of Medical Sciences, University of Campinas (UNICAMP), São Paulo, Brazil.
Marcelo Brum CorrêaHead and Neck Surgery Department, Oncology Center (CEON), Fornecedores de Cana Hospital, Piracicaba, São Paulo, Brazil.
Rodrigo Ribas Dias Dos ReisHead and Neck Surgery Department, Oncology Center (CEON), Fornecedores de Cana Hospital, Piracicaba, São Paulo, Brazil.
Luciana Schultz AmorimInstitute of Pathological Anatomy, São Paulo, Brazil.
Rachel Martins Marinho RobimInstitute of Pathological Anatomy, São Paulo, Brazil.
Clóvis Antônio Lopes PintoDepartment of Pathology, A. C. Camargo Cancer Center, São Paulo, Brazil.
Patricia Maria PeresiDepartment of Pathology, A. C. Camargo Cancer Center, São Paulo, Brazil.
Ana Lucia Noronha FranciscoDepartament of Pathology, School of Dentistry, University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
Felipe Paiva FonsecaDepartament of Pathology, School of Dentistry, University of Minas Gerais (UFMG), Belo Horizonte, Brazil.ORCID https://orcid.org/0000-0002-6657-4547
Luiz Paulo KowalskiDepartment of Head and Neck Surgery and Otorhinolaryngology, A. C. Camargo Cancer Center, São Paulo, Brazil.
Román CarlosPathology Section, Centro Clínico de Cabeza y Cuello/Hospital Herrera Llerandi, Guatemala City, Guatemala.
Fernanda Viviane MarianoDepartment of Pathology, Faculty of Medical Sciences, University of Campinas (UNICAMP), São Paulo, Brazil.
Albina AltemaniDepartment of Pathology, Faculty of Medical Sciences, University of Campinas (UNICAMP), São Paulo, Brazil.

Funding

Coordination for the Improvement of Higher Education Personnel (CAPES)Fundação de Amparo à Pesquisa do Estado de São Paulo 15/07304-0Fundação de Amparo à Pesquisa do Estado de São Paulo 15/10240-4Fundação de Amparo à Pesquisa do Estado de São Paulo 19/09419-0National Council for Scientific and Technological Development
6 · The paper itself

Abstract

backgroundMelanoma affects skin and mucosa and can be particularly aggressive when the lesion is an advanced cutaneous tumor or located in the sinonasal or oral mucosa. Reprogramming of energy metabolism has been defined as a hallmark of cancer; so this study aimed to verify the expression of proteins related to metabolism and cellular proliferation.

methodsImmunohistochemical analysis with antibodies adipophilin, FASN, GLUT-1, HIF-1α, and Ki-67 was performed in a series of 28 sinonasal melanomas (SM), 16 oral melanomas (OM), and 39 cutaneous melanomas (CM). For CM, 25 cases with matched lymph node metastases were analyzed, while 17 mucosal and 15 cutaneous melanocytic nevi served as controls.

resultsSM showed an increased frequency of undifferentiated cells, necrotic areas, and marked expression of adipophilin in comparison to OM. In metastatic CM, a significant increase of FASN expression was detected. However, the frequency of expression of this protein was not significantly different between primary tumors and their metastasis. Concerning adipophilin expression in CM with or without metastasis, no significant difference was found, whereas the Ki-67 proliferative index was significantly lower in metastatic tumors. Benign melanocytic lesions showed lower expression of all markers.

conclusionSM and OM show marked differences in metabolic phenotype alterations since SM are more frequently positive for adipophilin. In CM, the marked expression of FASN in metastatic tumors suggests that these proteins probably contribute to disease progression.

Indexed as

MelanomaMouth NeoplasmsNose NeoplasmsSkin NeoplasmsTumor MicroenvironmentAdultAgedAged, 80 and overBiomarkers, TumorCell ProliferationFatty Acid Synthase, Type IFemaleGlucose Transporter Type 1HumansHypoxia-Inducible Factor 1, alpha SubunitImmunohistochemistryBiomarkers, TumorFASN protein, humanFatty Acid Synthase, Type IGlucose Transporter Type 1HIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitKi-67 AntigenPerilipin-2PLIN2 protein, humanSLC2A1 protein, humancutaneous melanomaglycogenesislipogenesismetabolismoral melanomasinonasal melanoma

Identifiers

PMID40867038
PMCPMC12602135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.